Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA (Q44308395)

1 December 2017

Binding mode of chemically activated semiquinone free radicals from quinone anticancer agents to DNA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A549745

11 July 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A549745

11 July 2022

2

Chignell CF

1 reference

1 December 2017

B. K. Sinha

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A549745

11 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=549745

11 July 2022

publication date

1 December 1979

1 reference

full work available at URL

1 December 2017

https://api.elsevier.com/content/article/PII:0009279779901704?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

https://api.elsevier.com/content/article/PII:0009279779901704?httpAccept=text/plain

7 July 2023

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Chemico-biological Interactions

7 July 2023

published in

1 reference

1 December 2017

28

1 reference

1 December 2017

2-3

1 reference

1 December 2017

301-308

1 reference

Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia

1 December 2017

1

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Daunorubicin in the treatment of acute myelocytic leukaemia

7 July 2023

2

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

‘Daunomycin’, a New Antibiotic of the Rhodomycin Group

7 July 2023

4

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Daunomycin inhibition of DNA and RNA synthesis

7 July 2023

6

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

The inhibition of RNA polymerase by daunomycin

7 July 2023

7

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

A general mechanism for microsomal activation of quinone anticancer agents to free radicals

7 July 2023

11

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

The mode of interaction of mitomycin C with deoxyribonucleic acid and other polynucleotides in vitro

7 July 2023

12

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Structure-activity relation of daunorubicin and its peptide derivatives

7 July 2023

13

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Interaction specificity of the anthracyclines with deoxyribonucleic acid

7 July 2023

14

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

The formation of an azo anion free radical metabolite during the microsomal azo reduction of sulfonazo III

7 July 2023

15

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Synthsis and antitumor properties of bis(quinaldine) derivatives

7 July 2023

16

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Hydroxyl radical production by free and DNA-bound aminoquinone antibiotics and its role in DNA degradation. Electron spin resonance detection of hydroxyl radicals by spin trapping

7 July 2023

17

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Studies of the binding of actinomycin and related compounds to DNA.

7 July 2023

19

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Hedamycin and rubiflavin complexes with deoxyribonucleic acid and other polynucleotides.

7 July 2023

20

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

In vivo sister-chromatid exchange: A sensitive measure of DNA damage

7 July 2023

21

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

Bioactivation as a model for drug design bioreductive alkylation

7 July 2023

22

1 reference

https://api.crossref.org/works/10.1016/0009-2797(79)90170-4

7 July 2023

Identifiers

1 reference

1 December 2017

1 reference